This research does not provide a peptide treatment but rather identifies a peptide pathway that could be targeted to reduce eczema-associated itch, potentially through BNP receptor antagonists
Coverage for Zepbound depends on your Ontario provincial formulary and private insurance plan
Potential systemic anti-inflammatory effects could theoretically benefit multiple conditions characterized by chronic low-grade inflammation, including metabolic syndrome, cardiovascular disease, and certain autoimmune conditions
Any provider prescribing compounded GLP-1 formulations should be tracking your progress with periodic bloodwork and, ideally, body composition measurements (DEXA scan or bioimpedance) rather than relying solely on scale weight
The same study confirmed dose-dependent increases in GH without significant changes in other pituitary hormones (prolactin, TSH, LH, FSH, cortisol), supporting its selectivity for the GH axis